On the mend: Rising demand for biologic drugs and global trade will drive revenue

Over the past five years, the Brand Name Pharmaceutical Manufacturing industry has grappled with generating sales volumes, thanks to many provinces and territories implementing incentives to bolster generic drug utilization rates. As the cost discrepancy between generic and brand-name drugs has risen, many public and private payers have aimed to bolster generic drug use, intensifying competition for the industry. Still, industry revenue is expected to increase over the past five years, which can be attributed to robust demand for biologic drugs. Over the next five years, the industry is expected to exhibit growth, driven by increasing demand for biologics from an aging population. However, the industry will still contend with strong competition from generic drug makers...read more.

Industry Statistics & Market Size
Revenue
$7bn
Annual Growth 13-18
3.0%
Forecast Growth 18-23
Profit
Employment
17,566
Businesses
250

Industry Threats & Opportunities

  • Many pharmaceutical manufacturers will focus their product portfolio on developing biologic drugs
  • Many public and private payers have focused on bolstering generic drug utilization rates
  • The industry is expected to exhibit growth, due to robust demand for biologic drugs
  • Industry Report - Industry SWOT Analysis Chapter

    Over the 10 years to 2023, industry value added (IVA), which measures an industry's contribution to the overall economy, is expected to grow at an annualized rate of 3.3%. Comparatively, Canadian GDP is anticipated to rise at an annualized rate of 1.9% during the 10-year period. The industry is currently in the growth life cycle stage, which can be contested due to the maturity of industry products, though this has been offset by an uptick in demand for developing products (i.e. biologics). How...purchase to read more.

    Additional Insights for the Brand-Name Pharmaceutical Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Brand-Name Pharmaceutical Manufacturing Industry are

  • Establishment of brand names
  • Undertaking pharmaceutical and medicine R&D
  • Degree of globalization in the company
  • IBISWorld analysts also discuss how external factors such as Total health expenditure and Median age of population in the Brand-Name Pharmaceutical Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Brand-Name Pharmaceutical Manufacturing Industry?

    This industry develops prescription and over-the-counter products used to treat illnesses in humans and animals. Brand-name drugs have patent protection. This industry does not include nutritional supplement or cosmetics manufacturers.

    Industry Products
  • Nervous system and cardiovascular drugs
  • Antineoplastic and immunomodulating agents
  • Alimentary tract and metabolism drugs
  • Respiratory system and sensory organ drugs
  • Antiinfectives and blood drugs
  • Musculoskeletal system drugs
  • Genitourinary and hormonal drugs
  • Industry Activities
  • Pharmaceutical research and development
  • Manufacturing active ingredients used in pharmaceuticals
  • Manufacturing chemical pharmaceutical preparations
  • Manufacturing biological pharmaceutical products
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Total health expenditure
  • Median age of population
  • R&D expenditures by pharmaceutical patentees
  • Canadian-dollar effective exchange rate index

  • Current Performance
  • Patent cliffs
  • Public and private payers
  • International trade and industry landscape
  • Chart: Revenue Growth

  • Industry Outlook
  • Changing products and markets
  • Industry structure
  • Table: Brand-Name Pharmaceutical Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Brand-Name Pharmaceutical Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Supermarkets & Grocery Stores in Canada
  • Pharmacies & Drug Stores in Canada
  • Hospitals in Canada

  • Key Selling Industries
  • Biotechnology in Canada
  • Chemical Product Manufacturing in Canada
  • Medical Device Manufacturing in Canada
  • Medical Instrument & Supply Manufacturing in Canada
  • Navigational Instrument Manufacturing in Canada
  • Soap & Cleaning Compound Manufacturing in Canada

  • Products & Services
  • Nervous system and cardiovascular drugs
  • Antineoplastic and immunomodulating agents
  • Antiinfectives and blood drugs
  • Alimentary tract and metabolism drugs
  • Respiratory system and sensory organ drugs
  • Genitourinary and hormonal drugs
  • Other
  • Musculoskeletal system drugs
  • Chart: Brand-Name Pharmaceutical Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Public and private healthcare providers
  • Population demographics

  • Major Markets
  • Public sector
  • Private insurers
  • Canadian households
  • Chart: Major Market Segmentation for the Brand-Name Pharmaceutical Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Wages
  • Research and development
  • Other
  • Chart: Cost Structure Benchmarking – Sector vs Brand-Name Pharmaceutical Manufacturing

  • Basis of Competition
  • Internal competition
  • External competition

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Brand-Name Pharmaceutical Manufacturing Industry

  • Industry Globalization
    Pfizer Inc., Gilead Sciences Inc., Sanofi, Merck & Co. Inc.,
  • Table: Pfizer Inc. - financial performance
  • Table: Gilead Sciences Inc. - financial performance
  • Table: Sanofi - financial performance
  • Table: Merck & Co. Inc. - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Brand-Name Pharmaceutical Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Brand-Name Pharmaceutical Manufacturing Industry
    Includes:
  • Industry Revenue (2009-2023)
  • Industry Gross Product (2009-2023)
  • Establishments (2009-2023)
  • Businesses (2009-2023)
  • Employment (2009-2023)
  • Exports (2009-2023)
  • Imports (2009-2023)
  • Wages (2009-2023)
  • Total healthcare expenditure (2009-2023)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Biologic
  • A drug made from large-molecule living matter, as opposed to small-molecule chemicals.
  • Biosimilar
  • A drug derived from living organisms and marketed after the patent expiration of similar therapies. Also known as flow-on biologics or biogenerics.
  • Blockbuster Drug
  • A drug that generates annual sales of more than $1.0 billion.
  • Patent Cliff
  • The period when numerous patents on blockbuster drugs are set to expire.
  • What Our Customers Say

    Why buy this report?

    IBISWorld’s Brand-Name Pharmaceutical Manufacturing market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Brand-Name Pharmaceutical Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Brand-Name Pharmaceutical Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Brand-Name Pharmaceutical Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear